financetom
Business
financetom
/
Business
/
U.S. FDA approves Akebia's anemia drug
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
U.S. FDA approves Akebia's anemia drug
Mar 27, 2024 5:56 PM

March 27 (Reuters) - The U.S. Food and Drug

Administration approved Akebia Therapeutics' ( AKBA ) drug to

treat anemia caused by chronic kidney disease in dialysis

patients, the drugmaker said on Wednesday.

(Reporting by Pratik Jain, Vaibhav Sadhamta and Mrinmay Dey in

Bengaluru; Editing by Subhranshu Sahu)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2025 - www.financetom.com All Rights Reserved